Too much hype, not enough hope: Are balanced reporting and proper controls too much to expect from therapeutic studies in animal models of neuromuscular diseases that presage clinical trials in humans?

被引：4

作者：

Bretag, Allan ^{[1
]}

机构：

[1] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia

来源：

NEUROMUSCULAR DISORDERS | 2007年 / 17卷 / 03期

关键词：

D O I：

10.1016/j.nmd.2007.02.001

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：203 / 205

页数：3

共 19 条

[1] Nitric oxide release combined with nonsteroidal anti inflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy [J].

Brunelli, Silvia ;

Sciorati, Clara ;

D'Antona, Giuseppe ;

Innocenzi, Anna ;

Covarello, Diego ;

Galvez, Beatriz G. ;

Perrotta, Cristiana ;

Monopoli, Angela ;

Sanvito, Francesca ;

Bottinelli, Roberto ;

Ongini, Ennio ;

Cossu, Giulio ;

Clementi, Emilio .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) :264-269

[2] Treating muscular dystrophy with stem cells? [J].

Davies, Kay E. ;

Grounds, Miranda D. .

CELL, 2006, 127 (07) :1304-1306

[3] Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration [J].

De Angelis, L ;

Berghella, L ;

Coletta, M ;

Lattanzi, L ;

Zanchi, M ;

Cusella-De Angelis, MG ;

Ponzetto, C ;

Cossu, G .

JOURNAL OF CELL BIOLOGY, 1999, 147 (04) :869-877

[4] Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs [J].

Dell'Agnola, C ;

Wang, ZJ ;

Storb, R ;

Tapscott, SJ ;

Kuhr, CS ;

Hauschka, SD ;

Lee, RS ;

Sale, GE ;

Zellmer, E ;

Gisburne, S ;

Bogan, J ;

Kornegay, JN ;

Cooper, BJ ;

Gooley, TA ;

Little, MT .

BLOOD, 2004, 104 (13) :4311-4318

[5] Therapeutic efforts in Duchenne muscular dystrophy; the need for a common language between basic scientists and clinicians [J].

Dubowitz, V .

NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) :451-455

[6] Therapeutic possibilities in muscular dystrophy: the hope versus the hype [J].

Dubowitz, V .

NEUROMUSCULAR DISORDERS, 2002, 12 (02) :113-116

[7] Progressive muscular dystrophy in α-sarcoglycan-deficient mice [J].

Duclos, F ;

Straub, V ;

Moore, SA ;

Venzke, DP ;

Hrstka, RF ;

Crosbie, RH ;

Durbeej, M ;

Lebakken, CS ;

Ettinger, AJ ;

van der Meulen, J ;

Holt, KH ;

Lim, LE ;

Sanes, JR ;

Davidson, BL ;

Faulkner, JA ;

Williamson, R ;

Campbell, KP .

JOURNAL OF CELL BIOLOGY, 1998, 142 (06) :1461-1471

[8] Phenotypic correction of α-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector [J].

Fougerousse, Francoise ;

Bartoli, Marc ;

Poupiot, Jerome ;

Arandel, Ludovic ;

Durand, Muriel ;

Guerchet, Nicolas ;

Gicquel, Evelyne ;

Danos, Olivier ;

Richard, Isabelle .

MOLECULAR THERAPY, 2007, 15 (01) :53-61

[9]

Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085

[10] The allure of stem cell therapy for muscular dystrophy [J].

Grounds, Miranda D. ;

Davies, Kay E. .

NEUROMUSCULAR DISORDERS, 2007, 17 (03) :206-208

← 1 2 →